866-997-4948(US-Canada Toll Free)

Thalidomide Analysis and Market Forecasts from 2015 to 2020

Published By :

GlobalData

Published Date : Jul 2011

Category :

Therapeutic Area

No. of Pages : 27 Pages



GlobalDatas pharmaceuticals report, Thalidomide Analysis and Market Forecasts from 2015 to 2020 provides Thalidomide sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2015-2020). The report also includes information on Liver Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Scope
  • Therapy area profile including patient population for the US and EU5 
  • Analysis and review of Thalidomide including sales data 
  • Qualitative and quantitative assessment of market space
  • Analysis of the trends, drivers and restraints shaping and defining the markets
  • In-depth analysis of Thalidomide including efficacy, safety, pricing, competition and other details which influence its sales potential
  • Detailed sales forecast for 2015-2020 for Thalidomide in the US and EU5
Reasons to buy
  • Understand and capitalize by identifying products that are most likely to ensure a robust return
  • Stay ahead of competition by understanding the changing competitive landscape
  • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
  • Make more informed business decisions from insightful and in-depth analysis of the drugs performance 
  • Examine the historical sales performance of a drug in seven major markets
  • Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of content

1 Table of contents
1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Introduction 4
2.1 Liver Cancer Market 4
2.2 Epidemiology 4
2.3 Etiology 5
2.3.1 Hepatitis B Infection 5
2.3.2 Hepatitis C Infection 5
2.3.3 Alcohol 5
2.3.4 Aflatoxin B1 6
2.3.5 Hemochromatosis 6
2.3.6 Diabetes and Obesity 6
2.3.7 Cirrhosis 6
2.4 GlobalData Report Guidance 6

3 Liver Cancer : Market Characterization 7
3.1 Liver Cancer Market 7
3.2 Liver Cancer Market Forecasts and CAGR 7
3.3 Drivers for the Liver Cancer Market 7
3.3.1 High Incidence 8
3.3.2 High Mortality 8
3.3.3 Large Unmet Need 9
4 TumorNodeMetastases (TNM) Classification of Liver Cancer 10

5 Thalidomide 11
5.1 Introduction 11
5.2 Mechanism of Action 11
5.3 Clinical Studies 11
5.4 Factors Affecting Sales of Thalidomide 12
5.4.1 TACE Gold Standard Treatment 12
5.4.2 Teratogenicity 12
5.5 Drug Risk Benefit Score 13
5.5.1 Relative Efficacy 13
5.5.2 Safety 13
5.5.3 Compliance 13
5.5.4 Dosing Convenience 13
5.6 Intensity of Competition 13
5.7 Sales Forecasts 14
5.7.1 Target Patient Pool of Thalidomide 14
5.7.2 Dosing 14
5.7.3 Market Penetration 14
5.7.4 Annual Cost of Therapy 14
5.7.5 Sales Projections of Thalidomide 15

6 Liver Cancer Market: Appendix 23
6.1 Market Definitions 23
6.2 List of Abberiviations 23
6.3 Research Methodology 23
6.3.1 Coverage 23
6.3.2 Secondary Research 23
6.3.3 Forecasting 24
6.3.4 Number of Patients Approved to take the Drug 24
6.3.5 Net Penetration of Drug 25
6.3.6 Net Annual Dosing 25
6.3.7 Annual Cost of Therapy 25
6.3.8 Primary Research 25
6.3.9 Expert Panels 26
6.4 Drug Sales Estimates Model 26
6.5 Contact Us 26
6.6 Disclaimer 26
6.7 Sources 27

List of Table


Table 1: Liver Cancer, Incidences and Mortality, 20082030 4
Table 2: Drug Risk Benefit Score (DRB) 13
Table 3: Thalidomide, Liver Cancer, Global, Estimated Sales ($m), 20152020 15
Table 4: Thalidomide, Liver Cancer, The US, Estimated Sales ($m), 20152020 16
Table 5: Thalidomide, Liver Cancer, The UK, Estimated Sales ($m), 20162020 17
Table 6: Thalidomide, Liver Cancer, France, Estimated Sales ($m), 20162020 18
Table 7: Thalidomide, Liver Cancer, Germany, Estimated Sales ($m), 20162020 19
Table 8: Thalidomide, Liver Cancer, Italy, Estimated Sales ($m), 20162020 20
Table 9: Thalidomide, Liver Cancer, Spain, Estimated Sales ($m), 20162020 21

List of Chart


Figure 1: Fatality = [(% Distribution of Incidence) (% Distribution of Mortality)] of Most Common Cancers 5
Figure 2: Liver Cancer, Global, Market Size Forecast ($m), 20102020 7
Figure 3: Liver Cancer, Worldwide, Incidence (in millions), 20082030 8
Figure 4: Oncology, Worldwide, Incidence (in millions), 20082030 8
Figure 5: Liver Cancer, Worldwide, Mortality (in millions), 20082030 9
Figure 6: Classification of Liver Cancer 10
Figure 7: Clinical Trials Results, Thalidomide 12
Figure 8: Drug Model Diagram of Thalidomide 14
Figure 9: Thalidomide, Liver Cancer, Global, Estimated Sales ($m), 20152020 15
Figure 10: Thalidomide, Liver Cancer, The US, Estimated Sales ($m), 20152020 16
Figure 11: Thalidomide, Liver Cancer, The UK, Estimated Sales ($m), 20162020 17
Figure 12: Thalidomide, Liver Cancer, France, Estimated Sales ($m), 20162020 18
Figure 13: Thalidomide, Liver Cancer, Germany, Estimated Sales ($m), 20162020 19
Figure 14: Thalidomide, Liver Cancer, Italy, Estimated Sales ($m), 20162020 20
Figure 15: Thalidomide, Liver Cancer, Spain, Estimated Sales ($m), 20162020 21
Figure 16: Thalidomide, Liver Cancer, Global, Sales Distribution (%), 2020 22
Figure 17: Drug Model Diagram 24
Figure 18: Patients Approved for the Drug 25

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *